Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers

Bruce Molitoris, A. C. Alfrey, P. S. Alfrey, N. L. Miller

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Aluminum (Al) removal following deferoxamine (DFO) therapy in hemodialysis patients was evaluated in a paired-fashion comparing cuprophane (Travenol 12.11) and polysulfone (Fresenius F-80) dialyzers. Q(B) and Q(D) were held constant at 250 and 500 ml/min, respectively. The polysulfone dialyzer increased total plasma Al clearance from 20.0 ± 2.8 to 80.5 ± 7.6 ml/min (P < 0.01), and reduced the t 1/2 of plasma Al during hemodialysis from 538 ± 113 to 112 ± 12 min (P < 0.01). The polysulfone F-80 dialyzer increased Al removal during the first hour of hemodialysis from 518 ± 191 to 1812 ± 720 μg/hr (P < 0.01). During a four hour hemodialysis the F-80 dialyzer returned plasma Al levels to pre-DFO values (103 ± 36 vs. 93 ± 23, P < 0.05), suggesting complete removal of the DFO chelated Al complex. In one patient Al removal was evaluated using cuprophane, F-40, F-60 and F-80 dialyzers and the t 1/2 for Al removed decreased from 484.6 to 276.1 and 108 to 99 minutes, respectively. These data show the Fresenius F-80 polysulfone dialyzer effects the rapid removal of DFO-Al complexes. We propose use of the Fresenius F-80 dialyzer in conjunction with reduced DFO doses and i.m. administration of DFO the day prior to dialysis to limit DFO exposure as a method to decrease DFO-related side-effects in hemodialysis patients.

Original languageEnglish
Pages (from-to)98-101
Number of pages4
JournalKidney International
Volume34
Issue number1
StatePublished - 1988
Externally publishedYes

Fingerprint

Deferoxamine
Aluminum
Renal Dialysis
polysulfone P 1700
Dialysis

ASJC Scopus subject areas

  • Nephrology

Cite this

Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers. / Molitoris, Bruce; Alfrey, A. C.; Alfrey, P. S.; Miller, N. L.

In: Kidney International, Vol. 34, No. 1, 1988, p. 98-101.

Research output: Contribution to journalArticle

Molitoris, Bruce ; Alfrey, A. C. ; Alfrey, P. S. ; Miller, N. L. / Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers. In: Kidney International. 1988 ; Vol. 34, No. 1. pp. 98-101.
@article{b9a6c763225f4976bc8c44612578d77d,
title = "Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers",
abstract = "Aluminum (Al) removal following deferoxamine (DFO) therapy in hemodialysis patients was evaluated in a paired-fashion comparing cuprophane (Travenol 12.11) and polysulfone (Fresenius F-80) dialyzers. Q(B) and Q(D) were held constant at 250 and 500 ml/min, respectively. The polysulfone dialyzer increased total plasma Al clearance from 20.0 ± 2.8 to 80.5 ± 7.6 ml/min (P < 0.01), and reduced the t 1/2 of plasma Al during hemodialysis from 538 ± 113 to 112 ± 12 min (P < 0.01). The polysulfone F-80 dialyzer increased Al removal during the first hour of hemodialysis from 518 ± 191 to 1812 ± 720 μg/hr (P < 0.01). During a four hour hemodialysis the F-80 dialyzer returned plasma Al levels to pre-DFO values (103 ± 36 vs. 93 ± 23, P < 0.05), suggesting complete removal of the DFO chelated Al complex. In one patient Al removal was evaluated using cuprophane, F-40, F-60 and F-80 dialyzers and the t 1/2 for Al removed decreased from 484.6 to 276.1 and 108 to 99 minutes, respectively. These data show the Fresenius F-80 polysulfone dialyzer effects the rapid removal of DFO-Al complexes. We propose use of the Fresenius F-80 dialyzer in conjunction with reduced DFO doses and i.m. administration of DFO the day prior to dialysis to limit DFO exposure as a method to decrease DFO-related side-effects in hemodialysis patients.",
author = "Bruce Molitoris and Alfrey, {A. C.} and Alfrey, {P. S.} and Miller, {N. L.}",
year = "1988",
language = "English",
volume = "34",
pages = "98--101",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers

AU - Molitoris, Bruce

AU - Alfrey, A. C.

AU - Alfrey, P. S.

AU - Miller, N. L.

PY - 1988

Y1 - 1988

N2 - Aluminum (Al) removal following deferoxamine (DFO) therapy in hemodialysis patients was evaluated in a paired-fashion comparing cuprophane (Travenol 12.11) and polysulfone (Fresenius F-80) dialyzers. Q(B) and Q(D) were held constant at 250 and 500 ml/min, respectively. The polysulfone dialyzer increased total plasma Al clearance from 20.0 ± 2.8 to 80.5 ± 7.6 ml/min (P < 0.01), and reduced the t 1/2 of plasma Al during hemodialysis from 538 ± 113 to 112 ± 12 min (P < 0.01). The polysulfone F-80 dialyzer increased Al removal during the first hour of hemodialysis from 518 ± 191 to 1812 ± 720 μg/hr (P < 0.01). During a four hour hemodialysis the F-80 dialyzer returned plasma Al levels to pre-DFO values (103 ± 36 vs. 93 ± 23, P < 0.05), suggesting complete removal of the DFO chelated Al complex. In one patient Al removal was evaluated using cuprophane, F-40, F-60 and F-80 dialyzers and the t 1/2 for Al removed decreased from 484.6 to 276.1 and 108 to 99 minutes, respectively. These data show the Fresenius F-80 polysulfone dialyzer effects the rapid removal of DFO-Al complexes. We propose use of the Fresenius F-80 dialyzer in conjunction with reduced DFO doses and i.m. administration of DFO the day prior to dialysis to limit DFO exposure as a method to decrease DFO-related side-effects in hemodialysis patients.

AB - Aluminum (Al) removal following deferoxamine (DFO) therapy in hemodialysis patients was evaluated in a paired-fashion comparing cuprophane (Travenol 12.11) and polysulfone (Fresenius F-80) dialyzers. Q(B) and Q(D) were held constant at 250 and 500 ml/min, respectively. The polysulfone dialyzer increased total plasma Al clearance from 20.0 ± 2.8 to 80.5 ± 7.6 ml/min (P < 0.01), and reduced the t 1/2 of plasma Al during hemodialysis from 538 ± 113 to 112 ± 12 min (P < 0.01). The polysulfone F-80 dialyzer increased Al removal during the first hour of hemodialysis from 518 ± 191 to 1812 ± 720 μg/hr (P < 0.01). During a four hour hemodialysis the F-80 dialyzer returned plasma Al levels to pre-DFO values (103 ± 36 vs. 93 ± 23, P < 0.05), suggesting complete removal of the DFO chelated Al complex. In one patient Al removal was evaluated using cuprophane, F-40, F-60 and F-80 dialyzers and the t 1/2 for Al removed decreased from 484.6 to 276.1 and 108 to 99 minutes, respectively. These data show the Fresenius F-80 polysulfone dialyzer effects the rapid removal of DFO-Al complexes. We propose use of the Fresenius F-80 dialyzer in conjunction with reduced DFO doses and i.m. administration of DFO the day prior to dialysis to limit DFO exposure as a method to decrease DFO-related side-effects in hemodialysis patients.

UR - http://www.scopus.com/inward/record.url?scp=0023680084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023680084&partnerID=8YFLogxK

M3 - Article

C2 - 3172641

AN - SCOPUS:0023680084

VL - 34

SP - 98

EP - 101

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 1

ER -